PCRopsis Support: a) 1 mL, REF 787001; b) 0.25 mL, REF 787002; c) 25 uL, REF 787003; Improves t...
FDA Device Recall #Z-1301-2023 — Class II — February 21, 2023
Recall Summary
| Recall Number | Z-1301-2023 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 21, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Entopsis , Inc. |
| Location | Medley, FL |
| Product Type | Devices |
| Quantity | 94 units |
Product Description
PCRopsis Support: a) 1 mL, REF 787001; b) 0.25 mL, REF 787002; c) 25 uL, REF 787003; Improves the functionality of PCRopsis regents for select applications; nucleic acid extraction from a variety of biological samples
Reason for Recall
Presence of misleading label statements on the product label.
Distribution Pattern
Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania
Lot / Code Information
a) REF 787001, Lot Numbers: 4, Exp. 05/2023; b) REF 787002, Lot Numbers: 4, Exp. 05/2023; 5, Exp. 07/2023; c) REF 787003, Lot Numbers: 5 Exp. 07/2023
Other Recalls from Entopsis , Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1298-2023 | Class II | PCRopsis Lysis Beads, IVDD: a) 25 tubes , REF 5... | Feb 21, 2023 |
| Z-1299-2023 | Class II | PCRopsis Reagent RVD with RVD Enhancer: a) 1 ... | Feb 21, 2023 |
| Z-1295-2023 | Class II | PCRopsis BCSNano (1mL), REF 2276001; nucleic ac... | Feb 21, 2023 |
| Z-1300-2023 | Class II | PCRopsis Reagent RVD-RT, IVD: a) 1 mL, REF 78... | Feb 21, 2023 |
| Z-1297-2023 | Class II | PCRopsis Activator: a) 1.5mL, REF 228001; b) 0... | Feb 21, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.